Thromboelastography in Non-elective Cesarean Delivery

Completed

Conditions studied: Bleeding

In brief

The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Key facts

Study ID

NCT01514591

Run by

Stanford University

People needed

33

Starts

2011-08-01

Expected to finish

2013-06-01

Last updated by the study team

2013-06-21

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Obstetric in-patients
• Laboring patients with Epidurals for Labor Analgesia going for non-elective Cesarean
• Patients of all ethnic backgrounds will be included
• Singleton pregnancy
• ASA 1 or 2

You may not qualify if…

• Patients with underlying coagulation disorders.
• Patients with thrombocytopenia (platelet count <100).
• Patients with pregnancy-induced hypertension, pre-eclampsia.
• Patients requiring the following medications prior to surgery: NSAIDS, aspirin, anticoagulants.
• Patients requiring elective Cesarean delivery.
• Patients with significant obstetric or medical disease.
• No patients <18 years of age will be recruited.

Where it is running

• Lucile Packard Children's Hospital — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.